Nodality scores $3.5M for personal diagnostics
Nodality, a biotech company that makes diagnostics focused on cell pathways, has brought in $3.5 million of an expected $10 million round of equity, according to a filing with the SEC. Based in South San Francisco, its backers include Kleiner Perkins Caufield & Byers, Maverick Capital and TPG Biotechnology.
Next Story: JukeFly re-launches personal online music player
Previous Story: Augmented reality company Layar gets $1M boost, launches on Symbian
About the Author, Camille Ricketts
Camille was the lead writer for GreenBeat until August 2010. To reach VentureBeat's current writers, email tips@venturebeat.com.
